Randomized, open-label, phase II trial of dostarlimab (TSR-042), as maintenance therapy for patients with high-risk locally advanced cervical cancer after chemo-radiation: ATOMICC study
Por:
Oaknin, A, Iglesias, M, Alarcon, J, Javierre, G, Garcia, L, Santaballa, A, Manso, L, Romero, I, Ginesta, M, Churruca, C, Garcia, Y, Sanchez, A, Marquina, G, Pardo, B, Redondo, A, Rubio, M and Martin, A
Publicada:
1 sep 2020
Resumen:
Bronze
|